Literature DB >> 10930419

XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage.

R Datta1, E Oki, K Endo, V Biedermann, J Ren, D Kufe.   

Abstract

The IAP (inhibitor of apoptosis) family of anti-apoptotic proteins regulates programmed cell death. Of the six known human IAP-related proteins, XIAP is the most potent inhibitor. To study the mechanistic effects of XIAP on DNA damage-induced apoptosis, we prepared U-937 cells that stably overexpress XIAP. The results demonstrate that XIAP inhibits apoptosis induced by 1-[beta-d-arabinofuranosyl]cytosine (ara-C) and other genotoxic agents. XIAP had no detectable effect on ara-C-induced release of mitochondrial cytochrome c and attenuated cleavage of procaspase-9. In addition, we show that ara-C induces the association of XIAP with the cleaved fragments of caspase-9 and thereby inhibition of caspase-9 activity. The results also demonstrate that ara-C induces cleavage of procaspase-3 by a caspase-8-dependent mechanism and that XIAP inhibits caspase-3 activity. These results demonstrate that XIAP functions downstream of procaspase-9 cleavage as an inhibitor of both proteolytically processed caspase-9 and -3 in the cellular response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930419     DOI: 10.1074/jbc.M910231199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.

Authors:  Jian Ren; Deepak Raina; Wen Chen; Guilan Li; Lei Huang; Donald Kufe
Journal:  Mol Cancer Res       Date:  2006-11       Impact factor: 5.852

2.  Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.

Authors:  Yun Dai; Mohamed Rahmani; Paul Dent; Steven Grant
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation.

Authors:  D Conte; P Liston; J W Wong; K E Wright; R G Korneluk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.

Authors:  Prithviraj Bose; Yun Dai; Steven Grant
Journal:  Pharmacol Ther       Date:  2014-04-24       Impact factor: 12.310

5.  The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells.

Authors:  Takeo Nomura; Hiromitsu Mimata; Yusuke Takeuchi; Hideyuki Yamamoto; Eishichi Miyamoto; Yoshio Nomura
Journal:  Urol Res       Date:  2003-02-12

6.  Characterization of XIAP-deficient mice.

Authors:  H Harlin; S B Reffey; C S Duckett; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Prolactin-Stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells.

Authors:  N Krishnan; D J Buckley; M Zhang; J C Reed; A R Buckley
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

8.  Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts.

Authors:  Nezam Haider; Eloisa Arbustini; Sudhir Gupta; Han Liu; Navneet Narula; Roger Hajjar; Narain Moorjani; Stephen Westaby; Marc J Semigran; G William Dec; Y Chandrashekhar; Jagat Narula
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

9.  In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L.

Authors:  Chong Zhang; Shuang-shuang Zhou; Lin-yi Feng; Da-yong Zhang; Neng-ming Lin; Li-huang Zhang; Jian-ping Pan; Jun-bo Wang; Jie Li
Journal:  Acta Pharmacol Sin       Date:  2012-12-10       Impact factor: 6.150

10.  Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.

Authors:  B Z Carter; D H Mak; R Woessner; S Gross; W D Schober; Z Estrov; H Kantarjian; M Andreeff
Journal:  Leukemia       Date:  2009-05-21       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.